Physician profile
Irwin B Malament
NPI 1598739039
$1,765.87
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,549 · 2020: $107 · 2022: $110.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $340.51 | 2019-2020 | |
| Smith+Nephew, INC. | $290.07 | 2019 | |
| Medline Industries LP | $223.42 | 2019 | |
| Kci USA, INC. | $191.02 | 2019 | |
| Cardiovascular Systems INC. | $161.46 | 2019 | |
| Biocompatibles, INC. | $110.25 | 2019 | |
| Heron Therapeutics, INC. | $109.65 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $96.06 | 2019 | |
| Melinta Therapeutics, LLC | $52.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $48.73 | 2020 | |
| Stryker Corporation | $39.43 | 2019-2020 | |
| Organogenesis INC. | $29.90 | 2019-2020 | |
| Horizon Therapeutics Plc | $25.46 | 2019 | |
| Pfizer INC. | $24.29 | 2019 | |
| Integra Lifesciences Corporation | $11.92 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $11.22 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin Malament listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.